Leonard D Schaeffer
CIK 1016369 · last filed 2025-10-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AGN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SANTA MONICA, CA 90401
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| scPharmaceuticals Inc. (SCPH) Delisted | Director | 0 | $5.67 | $0 | $0 | 12 | 2025-10-07 |
| Walgreens Boots Alliance, Inc. (WBA) Delisted | Director | 1,512 | $11.98 | $18.1K | $144.4K | 5 | 2018-11-02 |
| Q | Director | 165,896 | $114.07 | $18.92M | $0 | 3 | 2016-05-06 |
| AMGN | Director | 18,202 | $444.63 | $8.09M | -$1.74M | 12 | 2013-04-30 |
| ALLERGAN INC (AGN) Delisted | Director | 47,503 | — | — | -$8.18M | 13 | 2012-03-23 |
Recent Filings · Page 2 of 5
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-21 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-20 | scPharmaceuticals Inc. (SCPH) Delisted | Exer (M) | +22,631 | $37.6K | EDGAR |
| 2017-11-21 | scPharmaceuticals Inc. (SCPH) Delisted | Conv (C) | +77,922 | $0 | EDGAR |
| 2017-11-03 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-03 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-06 | Q | Grant (A) | +775 | $0 | EDGAR |
| 2015-11-03 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-29 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Buy (P) | +1,500 | $144.4K | EDGAR |
| 2015-05-08 | Q | Grant (A) | +771 | $0 | EDGAR |
| 2013-05-09 | Q | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.